Results 121 to 130 of about 2,175,372 (155)

Targeting AKR1C1 overcomes lenvatinib resistance in hepatocellular carcinoma through the STAT3-ABC transporters pathway. [PDF]

J Gastrointest Oncol
Zhang Y, Zheng L, Feng AQ, Zhao CW, Xu XW, Wu H, Yu Y, Gu F, Chen YQ.   +8 more
europepmc   +1 more source

Malic enzyme 1 contributes to tumorigenesis and lenvatinib resistance in hepatocellular carcinoma via FSP1-dependent ferroptosis evasion. [PDF]

Cell Death Dis
Wu D, Xu H, Guo Y, Lu L, Han D, Chen L, Lei R, Li M, Wu W, He WZ, Yu Y, Fang X.   +11 more
europepmc   +1 more source

AARS1-mediated AKR1B10 lactylation stabilizes an aerobic glycolysis-positive feedback loop to drive lenvatinib resistance in hepatocellular carcinoma. [PDF]

Clin Transl Med
Liu Z, Yuan J, Su S, Han J, Zeng N, Ma Y, Chen N, Lv T.   +7 more
europepmc   +1 more source

Mechanism of Lenvatinib Resistance via Exosomal miRNA-132/Nrf2 Axis in Hepatocellular Carcinoma. [PDF]

Ann Gastroenterol Surg
Takasu C, Nakasu C, Saito Y, Morine Y, Ikemoto T, Yamada S, Teraoku H, Shimada M.   +7 more
europepmc   +1 more source

Aberrant activation of the PI3K/AKT/HIF‑1α pathway promotes glycolysis and lenvatinib resistance in liver cancer. [PDF]

Mol Med Rep
Wang J, Shi J, Mi L, Zhao M, Han G, Yin F.   +5 more
europepmc   +1 more source

Neuro-oncological ventral antigen 1 regulates liver cancer stem cell properties and Lenvatinib resistance via targeting SOX4. [PDF]

Cancer Cell Int
Lan H, Sun MM, Zhou PS, Liu XY, Wei WY, Lu K, Yang LX.   +6 more
europepmc   +1 more source

NEK7-induced phosphorylation of EGFR on serine 1070 drives the acquired lenvatinib resistance in hepatocellular carcinoma. [PDF]

Hepatology
Huang Q, Wang W, Ge Q, Xu D, Dong R, Chang R, Wu X, Mo J, Su C, Ning D, Liu Q, Liang H, Wang G, Chen J, Fu X, Chen X, Liang J, Zhang B.   +17 more
europepmc   +1 more source

CLEC4G Reverses Lenvatinib Resistance in Hepatocellular Carcinoma by Suppressing PD-1 Expression via the Wnt/<i>β</i>-Catenin Pathway. [PDF]

Int J Genomics
Xiao K, Yan J, He G, He B, Wang Q.
europepmc   +1 more source

miRNA-338-3p influences the liver cancer stem cells and lenvatinib resistance properties by targeting SOX4. [PDF]

Sci Rep
Yuan Y, Li HF, Liu ZM, Yu LP.
europepmc   +1 more source

CircRNA-mTOR Promotes Hepatocellular Carcinoma Progression and Lenvatinib Resistance Through the PSIP1/c-Myc Axis. [PDF]

Adv Sci (Weinh)
Tang Y, Yuan F, Cao M, Ren Y, Li Y, Yang G, Zhong Z, Liang H, Xiong Z, He Z, Lin N, Deng M, Yao Z.   +12 more
europepmc   +1 more source